Zymeworks Inc.
ZYME
$14.81
-$0.03-0.20%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 79.73% | -12.64% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 79.73% | -12.64% | |||
| Cost of Revenue | -3.61% | -3.57% | |||
| Gross Profit | 265.47% | -43.04% | |||
| SG&A Expenses | -11.98% | 4.94% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -6.30% | -0.99% | |||
| Operating Income | 97.37% | -15.29% | |||
| Income Before Tax | 109.63% | -24.44% | |||
| Income Tax Expenses | -137.50% | -91.32% | |||
| Earnings from Continuing Operations | 110.24% | 3.70% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 110.24% | 3.70% | |||
| EBIT | 97.37% | -15.29% | |||
| EBITDA | 107.89% | -19.76% | |||
| EPS Basic | 110.23% | 4.35% | |||
| Normalized Basic EPS | 109.61% | -23.64% | |||
| EPS Diluted | 109.86% | 3.65% | |||
| Normalized Diluted EPS | 109.35% | -23.59% | |||
| Average Basic Shares Outstanding | 0.22% | 0.68% | |||
| Average Diluted Shares Outstanding | 2.86% | 0.68% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||